82 related articles for article (PubMed ID: 17448679)
1. Place of residence effect on likelihood of surviving prostate cancer.
Gregorio DI; Huang L; DeChello LM; Samociuk H; Kulldorff M
Ann Epidemiol; 2007 Jul; 17(7):520-4. PubMed ID: 17448679
[TBL] [Abstract][Full Text] [Related]
2. Overall survival in the intervention arm of a randomized controlled screening trial for prostate cancer compared with a clinically diagnosed cohort.
Vis AN; Roemeling S; Reedijk AM; Otto SJ; Schröder FH
Eur Urol; 2008 Jan; 53(1):91-8. PubMed ID: 17583416
[TBL] [Abstract][Full Text] [Related]
3. Clusters of census tracts with high proportions of men with distant-stage prostate cancer incidence in New Jersey, 1995 to 1999.
Abe T; Martin IB; Roche LM
Am J Prev Med; 2006 Feb; 30(2 Suppl):S60-6. PubMed ID: 16458791
[TBL] [Abstract][Full Text] [Related]
4. Explaining the race difference in prostate cancer stage at diagnosis.
Jones BA; Liu WL; Araujo AB; Kasl SV; Silvera SN; Soler-Vilá H; Curnen MG; Dubrow R
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2825-34. PubMed ID: 18829446
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
6. Missing stage and grade in Maryland prostate cancer surveillance data, 1992-1997.
Klassen AC; Curriero F; Kulldorff M; Alberg AJ; Platz EA; Neloms ST
Am J Prev Med; 2006 Feb; 30(2 Suppl):S77-87. PubMed ID: 16458794
[TBL] [Abstract][Full Text] [Related]
7. Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras.
Sun L; Caire AA; Robertson CN; George DJ; Polascik TJ; Maloney KE; Walther PJ; Stackhouse DA; Lack BD; Albala DM; Moul JW
J Urol; 2009 Nov; 182(5):2242-8. PubMed ID: 19758616
[TBL] [Abstract][Full Text] [Related]
8. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer incidence in light of the spatial distribution of another screening-detectable cancer.
Gregorio DI; Samociuk H
Spat Spatiotemporal Epidemiol; 2013 Sep; 6():1-6. PubMed ID: 23973176
[TBL] [Abstract][Full Text] [Related]
10. The 20-Yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: the prognostic value of tumour ploidy and comorbidity.
Adolfsson J; Tribukait B; Levitt S
Eur Urol; 2007 Oct; 52(4):1028-35. PubMed ID: 17467883
[TBL] [Abstract][Full Text] [Related]
11. Improved survival of patients with prostate cancer in northern Denmark, 1985-2004.
Lund L; Jacobsen J; Borre M; Larsen EH; Graversen PH; Sørensen HT; Nørgaard M;
Scand J Urol Nephrol; 2007; 41(4):308-13. PubMed ID: 17763222
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer progression and survival in BRCA2 mutation carriers.
Tryggvadóttir L; Vidarsdóttir L; Thorgeirsson T; Jonasson JG; Olafsdóttir EJ; Olafsdóttir GH; Rafnar T; Thorlacius S; Jonsson E; Eyfjord JE; Tulinius H
J Natl Cancer Inst; 2007 Jun; 99(12):929-35. PubMed ID: 17565157
[TBL] [Abstract][Full Text] [Related]
14. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
15. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
Barocas DA; Cowan JE; Smith JA; Carroll PR;
J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
[TBL] [Abstract][Full Text] [Related]
16. Gleason score 7 screen-detected prostate cancers initially managed expectantly: outcomes in 50 men.
van den Bergh RC; Roemeling S; Roobol MJ; Aus G; Hugosson J; Rannikko AS; Tammela TL; Bangma CH; Schröder FH
BJU Int; 2009 Jun; 103(11):1472-7. PubMed ID: 19154509
[TBL] [Abstract][Full Text] [Related]
17. Travel times to health care and survival from cancers in Northern England.
Jones AP; Haynes R; Sauerzapf V; Crawford SM; Zhao H; Forman D
Eur J Cancer; 2008 Jan; 44(2):269-74. PubMed ID: 17888651
[TBL] [Abstract][Full Text] [Related]
18. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
[TBL] [Abstract][Full Text] [Related]
19. Survival outcomes in men receiving androgen-deprivation therapy as primary or salvage treatment for localized or advanced prostate cancer: 20-year single-centre experience.
DiBlasio CJ; Malcolm JB; Hammett J; Wan JY; Aleman MA; Patterson AL; Wake RW; Derweesh IH
BJU Int; 2009 Nov; 104(9):1208-14. PubMed ID: 19388987
[TBL] [Abstract][Full Text] [Related]
20. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]